Review




Structured Review

SuperArray Bioscience Corporation control plasmid containing a scrambled shrna sequence
RNAi mediated down-regulation of IRAK1 expression. HaCaT cells were transfected with expression constructs encoding a scrambled negative control <t>shRNA</t> <t>sequence</t> or an IRAK1 specific shRNA. Geneticin selected cells were treated with medium only (Med) or 10 ng/ml IL-1β. After 24 hours cells were lysed in PBS with 2 M urea and 0.85% SDS and proteins examined by Western blotting. IRAK1 and GAPDH were detected using polyclonal anti-IRAK1 and anti-GAPDH rabbit antibodies, respectively.
Control Plasmid Containing A Scrambled Shrna Sequence, supplied by SuperArray Bioscience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/control plasmid containing a scrambled shrna sequence/product/SuperArray Bioscience Corporation
Average 90 stars, based on 1 article reviews
control plasmid containing a scrambled shrna sequence - by Bioz Stars, 2026-04
90/100 stars

Images

1) Product Images from "Interleukin-1 regulates keratinocyte expression of T cell targeting chemokines through interleukin-1 receptor associated kinase-1 (IRAK1) dependent and independent pathways"

Article Title: Interleukin-1 regulates keratinocyte expression of T cell targeting chemokines through interleukin-1 receptor associated kinase-1 (IRAK1) dependent and independent pathways

Journal:

doi: 10.1016/j.cellsig.2009.01.005

RNAi mediated down-regulation of IRAK1 expression. HaCaT cells were transfected with expression constructs encoding a scrambled negative control shRNA sequence or an IRAK1 specific shRNA. Geneticin selected cells were treated with medium only (Med) or 10 ng/ml IL-1β. After 24 hours cells were lysed in PBS with 2 M urea and 0.85% SDS and proteins examined by Western blotting. IRAK1 and GAPDH were detected using polyclonal anti-IRAK1 and anti-GAPDH rabbit antibodies, respectively.
Figure Legend Snippet: RNAi mediated down-regulation of IRAK1 expression. HaCaT cells were transfected with expression constructs encoding a scrambled negative control shRNA sequence or an IRAK1 specific shRNA. Geneticin selected cells were treated with medium only (Med) or 10 ng/ml IL-1β. After 24 hours cells were lysed in PBS with 2 M urea and 0.85% SDS and proteins examined by Western blotting. IRAK1 and GAPDH were detected using polyclonal anti-IRAK1 and anti-GAPDH rabbit antibodies, respectively.

Techniques Used: Expressing, Transfection, Construct, Negative Control, shRNA, Sequencing, Western Blot

IRAK1 is required for CC chemokine secretion. (A and B), HaCaT cells were transfected with expression constructs encoding a scrambled negative control shRNA sequence (open bars) or IRAK1 specific shRNA (filled bars). (C and D), cells were transfected with either an empty (open bars) or IRAK1(1-217) (filled bars) expression construct. Geneticin selected cells were treated with medium only, 10 ng/ml IL-1β or 50 ng/ml TNF-α for 24 hours. Secretion of CCL5 (A and C) and CCL20 (B and D) was determined by ELISA. Expression of CCL5 and CCL20 in the control cells (open bars, scrambled shRNA (A and B) or empty vector (C and D)) was defined as 100 pct. Expression of CCL5 and CCL20 in the IRAK1 targeted cells (filled bars, IRAK1 specific shRNA (A and B) or IRAK1(1-217) expression vector (C and D)) is graphically represented relative to the control cells. * p < 0.05 compared to control cells transfected with scrambled shRNA plasmid (A and B) or empty vector (C and D) and receiving the same treatment.
Figure Legend Snippet: IRAK1 is required for CC chemokine secretion. (A and B), HaCaT cells were transfected with expression constructs encoding a scrambled negative control shRNA sequence (open bars) or IRAK1 specific shRNA (filled bars). (C and D), cells were transfected with either an empty (open bars) or IRAK1(1-217) (filled bars) expression construct. Geneticin selected cells were treated with medium only, 10 ng/ml IL-1β or 50 ng/ml TNF-α for 24 hours. Secretion of CCL5 (A and C) and CCL20 (B and D) was determined by ELISA. Expression of CCL5 and CCL20 in the control cells (open bars, scrambled shRNA (A and B) or empty vector (C and D)) was defined as 100 pct. Expression of CCL5 and CCL20 in the IRAK1 targeted cells (filled bars, IRAK1 specific shRNA (A and B) or IRAK1(1-217) expression vector (C and D)) is graphically represented relative to the control cells. * p < 0.05 compared to control cells transfected with scrambled shRNA plasmid (A and B) or empty vector (C and D) and receiving the same treatment.

Techniques Used: Transfection, Expressing, Construct, Negative Control, shRNA, Sequencing, Enzyme-linked Immunosorbent Assay, Control, Plasmid Preparation

IL-1β enhancement of IFN-γ induced CXC chemokine expression is IRAK1 independent. A, HaCaT cells were transfected with expression constructs encoding a scrambled negative control shRNA sequence (open bars) or IRAK1 specific shRNA (filled bars). B, cells were transfected with either an empty (open bars) or IRAK1(1-217) (filled bars) expression construct. Geneticin selected cells were treated with 20 ng/ml IFN-γ or 20 ng/ml IFN-γ plus 10 ng/ml IL-1β for 2 hours. Expression of CXC chemokine mRNAs was examined using real-time RT-PCR. Expression of the individual CXC chemokine mRNA in response to co-treatment with IFN-β+ IL-1β is graphically represented relative to expression induced by IFN-γ alone. * p < 0.05 compared to cells transfected with the same vector and treated with IFN-γ only. ** p < 0.01 compared to cells transfected with the same vector and treated with IFN-γ only. # p < 0.05 compared to control cells transfected with empty vector and receiving the same treatment.
Figure Legend Snippet: IL-1β enhancement of IFN-γ induced CXC chemokine expression is IRAK1 independent. A, HaCaT cells were transfected with expression constructs encoding a scrambled negative control shRNA sequence (open bars) or IRAK1 specific shRNA (filled bars). B, cells were transfected with either an empty (open bars) or IRAK1(1-217) (filled bars) expression construct. Geneticin selected cells were treated with 20 ng/ml IFN-γ or 20 ng/ml IFN-γ plus 10 ng/ml IL-1β for 2 hours. Expression of CXC chemokine mRNAs was examined using real-time RT-PCR. Expression of the individual CXC chemokine mRNA in response to co-treatment with IFN-β+ IL-1β is graphically represented relative to expression induced by IFN-γ alone. * p < 0.05 compared to cells transfected with the same vector and treated with IFN-γ only. ** p < 0.01 compared to cells transfected with the same vector and treated with IFN-γ only. # p < 0.05 compared to control cells transfected with empty vector and receiving the same treatment.

Techniques Used: Expressing, Transfection, Construct, Negative Control, shRNA, Sequencing, Quantitative RT-PCR, Plasmid Preparation, Control



Similar Products

90
Santa Cruz Biotechnology control plasmid containing a scrambled shrna sequence
Control Plasmid Containing A Scrambled Shrna Sequence, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/control plasmid containing a scrambled shrna sequence/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
control plasmid containing a scrambled shrna sequence - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
OriGene control plasmid containing the scramble shrna sequence
Control Plasmid Containing The Scramble Shrna Sequence, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/control plasmid containing the scramble shrna sequence/product/OriGene
Average 90 stars, based on 1 article reviews
control plasmid containing the scramble shrna sequence - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Shanghai Genechem Ltd core lentiviral plasmids containing shrnas targeting her2/integrin β5 or scrambled sequence as negative control
Core Lentiviral Plasmids Containing Shrnas Targeting Her2/Integrin β5 Or Scrambled Sequence As Negative Control, supplied by Shanghai Genechem Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/core lentiviral plasmids containing shrnas targeting her2/integrin β5 or scrambled sequence as negative control/product/Shanghai Genechem Ltd
Average 90 stars, based on 1 article reviews
core lentiviral plasmids containing shrnas targeting her2/integrin β5 or scrambled sequence as negative control - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
OriGene plasmids containing mdk shrna or scrambled control sequences
Plasmids Containing Mdk Shrna Or Scrambled Control Sequences, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plasmids containing mdk shrna or scrambled control sequences/product/OriGene
Average 90 stars, based on 1 article reviews
plasmids containing mdk shrna or scrambled control sequences - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Millipore control shrna plasmid containing a scrambled shrna sequence
Control Shrna Plasmid Containing A Scrambled Shrna Sequence, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/control shrna plasmid containing a scrambled shrna sequence/product/Millipore
Average 90 stars, based on 1 article reviews
control shrna plasmid containing a scrambled shrna sequence - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Qiagen plasmids containing shrna sequences cyp27b1 scrambled negative control shrna
Plasmids Containing Shrna Sequences Cyp27b1 Scrambled Negative Control Shrna, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plasmids containing shrna sequences cyp27b1 scrambled negative control shrna/product/Qiagen
Average 90 stars, based on 1 article reviews
plasmids containing shrna sequences cyp27b1 scrambled negative control shrna - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
SuperArray Bioscience Corporation control plasmid containing a scrambled shrna sequence
RNAi mediated down-regulation of IRAK1 expression. HaCaT cells were transfected with expression constructs encoding a scrambled negative control <t>shRNA</t> <t>sequence</t> or an IRAK1 specific shRNA. Geneticin selected cells were treated with medium only (Med) or 10 ng/ml IL-1β. After 24 hours cells were lysed in PBS with 2 M urea and 0.85% SDS and proteins examined by Western blotting. IRAK1 and GAPDH were detected using polyclonal anti-IRAK1 and anti-GAPDH rabbit antibodies, respectively.
Control Plasmid Containing A Scrambled Shrna Sequence, supplied by SuperArray Bioscience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/control plasmid containing a scrambled shrna sequence/product/SuperArray Bioscience Corporation
Average 90 stars, based on 1 article reviews
control plasmid containing a scrambled shrna sequence - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


RNAi mediated down-regulation of IRAK1 expression. HaCaT cells were transfected with expression constructs encoding a scrambled negative control shRNA sequence or an IRAK1 specific shRNA. Geneticin selected cells were treated with medium only (Med) or 10 ng/ml IL-1β. After 24 hours cells were lysed in PBS with 2 M urea and 0.85% SDS and proteins examined by Western blotting. IRAK1 and GAPDH were detected using polyclonal anti-IRAK1 and anti-GAPDH rabbit antibodies, respectively.

Journal:

Article Title: Interleukin-1 regulates keratinocyte expression of T cell targeting chemokines through interleukin-1 receptor associated kinase-1 (IRAK1) dependent and independent pathways

doi: 10.1016/j.cellsig.2009.01.005

Figure Lengend Snippet: RNAi mediated down-regulation of IRAK1 expression. HaCaT cells were transfected with expression constructs encoding a scrambled negative control shRNA sequence or an IRAK1 specific shRNA. Geneticin selected cells were treated with medium only (Med) or 10 ng/ml IL-1β. After 24 hours cells were lysed in PBS with 2 M urea and 0.85% SDS and proteins examined by Western blotting. IRAK1 and GAPDH were detected using polyclonal anti-IRAK1 and anti-GAPDH rabbit antibodies, respectively.

Article Snippet: Control plasmid containing a scrambled shRNA sequence was also obtained from SuperArray.

Techniques: Expressing, Transfection, Construct, Negative Control, shRNA, Sequencing, Western Blot

IRAK1 is required for CC chemokine secretion. (A and B), HaCaT cells were transfected with expression constructs encoding a scrambled negative control shRNA sequence (open bars) or IRAK1 specific shRNA (filled bars). (C and D), cells were transfected with either an empty (open bars) or IRAK1(1-217) (filled bars) expression construct. Geneticin selected cells were treated with medium only, 10 ng/ml IL-1β or 50 ng/ml TNF-α for 24 hours. Secretion of CCL5 (A and C) and CCL20 (B and D) was determined by ELISA. Expression of CCL5 and CCL20 in the control cells (open bars, scrambled shRNA (A and B) or empty vector (C and D)) was defined as 100 pct. Expression of CCL5 and CCL20 in the IRAK1 targeted cells (filled bars, IRAK1 specific shRNA (A and B) or IRAK1(1-217) expression vector (C and D)) is graphically represented relative to the control cells. * p < 0.05 compared to control cells transfected with scrambled shRNA plasmid (A and B) or empty vector (C and D) and receiving the same treatment.

Journal:

Article Title: Interleukin-1 regulates keratinocyte expression of T cell targeting chemokines through interleukin-1 receptor associated kinase-1 (IRAK1) dependent and independent pathways

doi: 10.1016/j.cellsig.2009.01.005

Figure Lengend Snippet: IRAK1 is required for CC chemokine secretion. (A and B), HaCaT cells were transfected with expression constructs encoding a scrambled negative control shRNA sequence (open bars) or IRAK1 specific shRNA (filled bars). (C and D), cells were transfected with either an empty (open bars) or IRAK1(1-217) (filled bars) expression construct. Geneticin selected cells were treated with medium only, 10 ng/ml IL-1β or 50 ng/ml TNF-α for 24 hours. Secretion of CCL5 (A and C) and CCL20 (B and D) was determined by ELISA. Expression of CCL5 and CCL20 in the control cells (open bars, scrambled shRNA (A and B) or empty vector (C and D)) was defined as 100 pct. Expression of CCL5 and CCL20 in the IRAK1 targeted cells (filled bars, IRAK1 specific shRNA (A and B) or IRAK1(1-217) expression vector (C and D)) is graphically represented relative to the control cells. * p < 0.05 compared to control cells transfected with scrambled shRNA plasmid (A and B) or empty vector (C and D) and receiving the same treatment.

Article Snippet: Control plasmid containing a scrambled shRNA sequence was also obtained from SuperArray.

Techniques: Transfection, Expressing, Construct, Negative Control, shRNA, Sequencing, Enzyme-linked Immunosorbent Assay, Control, Plasmid Preparation

IL-1β enhancement of IFN-γ induced CXC chemokine expression is IRAK1 independent. A, HaCaT cells were transfected with expression constructs encoding a scrambled negative control shRNA sequence (open bars) or IRAK1 specific shRNA (filled bars). B, cells were transfected with either an empty (open bars) or IRAK1(1-217) (filled bars) expression construct. Geneticin selected cells were treated with 20 ng/ml IFN-γ or 20 ng/ml IFN-γ plus 10 ng/ml IL-1β for 2 hours. Expression of CXC chemokine mRNAs was examined using real-time RT-PCR. Expression of the individual CXC chemokine mRNA in response to co-treatment with IFN-β+ IL-1β is graphically represented relative to expression induced by IFN-γ alone. * p < 0.05 compared to cells transfected with the same vector and treated with IFN-γ only. ** p < 0.01 compared to cells transfected with the same vector and treated with IFN-γ only. # p < 0.05 compared to control cells transfected with empty vector and receiving the same treatment.

Journal:

Article Title: Interleukin-1 regulates keratinocyte expression of T cell targeting chemokines through interleukin-1 receptor associated kinase-1 (IRAK1) dependent and independent pathways

doi: 10.1016/j.cellsig.2009.01.005

Figure Lengend Snippet: IL-1β enhancement of IFN-γ induced CXC chemokine expression is IRAK1 independent. A, HaCaT cells were transfected with expression constructs encoding a scrambled negative control shRNA sequence (open bars) or IRAK1 specific shRNA (filled bars). B, cells were transfected with either an empty (open bars) or IRAK1(1-217) (filled bars) expression construct. Geneticin selected cells were treated with 20 ng/ml IFN-γ or 20 ng/ml IFN-γ plus 10 ng/ml IL-1β for 2 hours. Expression of CXC chemokine mRNAs was examined using real-time RT-PCR. Expression of the individual CXC chemokine mRNA in response to co-treatment with IFN-β+ IL-1β is graphically represented relative to expression induced by IFN-γ alone. * p < 0.05 compared to cells transfected with the same vector and treated with IFN-γ only. ** p < 0.01 compared to cells transfected with the same vector and treated with IFN-γ only. # p < 0.05 compared to control cells transfected with empty vector and receiving the same treatment.

Article Snippet: Control plasmid containing a scrambled shRNA sequence was also obtained from SuperArray.

Techniques: Expressing, Transfection, Construct, Negative Control, shRNA, Sequencing, Quantitative RT-PCR, Plasmid Preparation, Control